Yükleniyor...

Advertisement

Lavie Bio Appoints Guri Oron As CEO

RTTNews | 1106 gün önce

Lavie Bio Appoints Guri Oron As CEO

(RTTNews) - Lavie Bio Ltd., a subsidiary of Evogene Ltd. (EVGN), announced Wednesday the appointment of Guri Oron as Chief Executive Officer of Lavie Bio, effective as of September 18, 2022.

Oron is a veteran executive in multi-disciplinary, deep-tech organizations, leading medical device and ag-tech companies from inception to market. He brings over 20 years of extensive experience at various early-stage technology companies both in Israel and internationally, most recently at Viridix Ltd., an ag-tech company focused on precision irrigation.

Previously, Oron was the CEO for seven years at BlueWind Medical Ltd., an active implantable medical device company. Prior to that, he served as CEO and co-founder at Cybotech Ltd. and as VP R&D at BrainsGate Ltd.

Etiketler: EVGN

read more

Syngenta Crop, Lavie Bio Partner To Discover And Develop New Biological Insecticidal Solutions

Syngenta Crop, Lavie Bio Partner To Discover And Develop New Biological Insecticidal Solutions

Swiss agricultural innovation firm Syngenta Crop Protection and Israel's Lavie Bio Ltd., a leading ag-biologicals company and a subsidiary of Evogene Ltd. (EVGN), announced Tuesday an agreement for the discovery and development of new biological insecticidal solutions.

RTTNews | 582 gün önce

Evogene's Lavie Bio Inks Licensing Agreement For Bio-Fungicides With Corteva Agriscience

Evogene's Lavie Bio Inks Licensing Agreement For Bio-Fungicides With Corteva Agriscience

Lavie Bio Ltd., a subsidiary of ag-biologicals company Evogene Ltd. (EVGN) announced on Monday a licensing agreement with ag innovation company Corteva Inc. (CTVA), that grants Corteva exclusive rights to further develop and commercialize the lead bio-fungicide product candidates targeting fruit rots and powdery mildew, which were discovered and developed by Lavie Bio.

RTTNews | 800 gün önce

Bay Street Likely To Open Slightly Higher

Bay Street Likely To Open Slightly Higher

Modestly higher futures point to a slightly positive start for the Canadian market on Wednesday. However, uncertainty about further interest rate cuts by the Fed this year, and worries about valuations may render the mood cautious and limit market's upside.

RTTNews | 21 dakika önce

U.S. Dollar Extends Rise Amid Fed Chair Powell Comments

U.S. Dollar Extends Rise Amid Fed Chair Powell Comments

The U.S. dollar continued to be strong against other major currencies in the European session on Wednesday, weighed down by Federal Reserve Chairman Jerome Powell's comments that equity prices are fairly highly valued by many measures.

RTTNews | 38 dakika önce

FTSE 100 Modestly Lower In Cautious Trade

FTSE 100 Modestly Lower In Cautious Trade

U.K. stocks are turning in a mixed performance in cautious trade on Wednesday. Uncertainty about Fed interest rate outlook, and on comments from Fed Chair Jerome Powell's warning that equity valuations are stretched.

RTTNews | 1s 0 dakika önce

CAC 40 Drifts Lower On Valuation Concerns, Rate Uncertainty

CAC 40 Drifts Lower On Valuation Concerns, Rate Uncertainty

French stocks are showing some weakness on Wednesday amid apprehensions about the outlook for Fed rate cuts, and Fed Chair Jerome Powell's comments that equity valuations are high.

RTTNews | 1s 40 dakika önce

Sensex, Nifty Extend Declines For Fourth Day

Sensex, Nifty Extend Declines For Fourth Day

Indian shares ended lower for a fourth day running on Wednesday, with trade-related concerns, rising oil prices and continued selling by foreign investors keeping investors on edge.

RTTNews | 2s 14 dakika önce

U.S. Dollar Rises Against Majors

U.S. Dollar Rises Against Majors

The U.S. dollar strengthened against other major currencies in the European session on Wednesday.

RTTNews | 2s 25 dakika önce

Şartlar | Gizlilik | Site Haritası | Site Map Calendar

© 2025 Myfxbook Ltd. Her hakkı saklıdır.

YÜKSEK RİSK UYARI: Döviz trade’i, tüm yatırımcılar için uygun olmayabilecek yüksek düzeyde risk taşır. Kaldıraç, ek risk ve zarara maruz kalma yaratır. Döviz trade’i yapmaya karar vermeden önce yatırım hedeflerinizi, deneyim seviyenizi ve risk toleransınızı dikkatlice değerlendirin. İlk yatırımınızın bir kısmını veya tamamını kaybedebilirsiniz. Kaybetmeyi göze alamayacağınız parayla yatırım yapmayın. Döviz trade’i ile ilgili riskler konusunda kendinizi eğitin ve herhangi bir sorunuz varsa bağımsız bir finans veya vergi danışmanından tavsiye alın. Her türlü veri ve bilgi 'olduğu gibi' yalnızca bilgilendirme amaçlıdır ve trading amaçları veya tavsiye amaçlı değildir. Geçmiş performans gelecekteki sonuçların göstergesi değildir.